Citalopram Hydrobromide (Celexa) Drug Study


CitaploramGeneric Name: citalopram hydrobromide

Brand Names: Celexa, Co Citalopram (CAN)

Drug classes: Antidepressant, SSRI

Pregnancy Category C

Therapeutic actions

Potentiates serotonergic activity in the CNS by inhibiting neuronal reuptake of serotonin, resulting in antidepressant effect, with little effect on norepinephrine or dopamine reuptake.

Indications
  • Treatment of depression, particularly effective in major depressive disorders
  • Unlabeled uses: OCD, panic disorder, PMDD, social phobia, trichotillomania, PTSD
Contraindications and cautions
  • Contraindicated with MAOI use; allergy to drug or any component of the drug or other SSRIs; concomitant use of pimozide.
  • Use cautiously with renal or hepatic impairment, pregnancy, lactation, and in patients who are elderly or suicidal.

Available forms:  Tablets—10, 20, 40 mg; oral solution—2 mg/mL; orally disintegrating tablets—10, 20, 40 mg

Dosages

ADULTS

Initially, 20 mg/day PO as a single daily dose. May be increased to 40 mg/day if needed no less than an interval of 1 wk.

PEDIATRIC PATIENTS

Safety and efficacy not established.

GERIATRIC PATIENTS OR PATIENTS WITH RENAL OR HEPATIC IMPAIRMENT

20 mg/day PO as a single dose; increase to 40 mg/day only if clearly needed and patient is not responding.

Pharmacokinetics

RouteOnsetPeak
OralSlow2–4 hr

 

Metabolism: Hepatic; T1/2: 35 hr

Distribution: Crosses placenta; enters breast milk

Excretion: Urine

Adverse effects
  • CNS: Somnolence, dizziness, insomnia, tremor, nervousness, headache, anxiety, paresthesia, blurred vision
  • CV: Palpitations, vasodilation, orthostatic hypotension, hypertension
  • Dermatologic: Sweating, rash, redness
  • GI: Nausea, dry mouth, constipation, diarrhea, anorexia, flatulence, vomiting
  • GU: Ejaculatory disorders
  • Respiratory: Sinusitis, URI, cough, rhinitis
Interactions

Drug-drug

  • Increased citalopram levels and toxicity if taken with MAOIs; ensure that patient has been off the MAOI for at least 14 days before administering citalopram
  • Increased citalopram levels with azole antifungals, macrolides
  • Possible severe adverse effects if combined with TCAs, erythromycin; use caution
  • Possible increased effects of beta blockers; monitor patient and reduce beta blocker dose as needed
  • Possible increased bleeding with warfarin, monitor patient carefully
  • Risk of prolonged QT interval and potentially fatal cardiac arrhythmias if combined with pimozide; avoid this combination

Drug-alternative therapy

  • Increased risk of severe reaction if combined with St. John’s wort.
Nursing considerations

CLINICAL ALERT!

Name confusion has occurred between Celexa (citalopram), Celebrex (celecoxib), Xanax (alprazolam), and Cerebyx (fosphenytoin); use caution.

Assessment

  • History: MAOI use; allergy to drug or any component of the drug; renal or hepatic impairment, the elderly, pregnancy, lactation, suicidal tendencies
  • Physical: Orientation, reflexes; P, BP, perfusion; bowel sounds, normal output; urinary output; liver evaluation; LFTs, renal function tests

Interventions

  • BLACK BOX WARNING: Be aware of increased risk of suicidality in children and adolescents; monitor accordingly.
  • Administer once a day, in the morning; may be taken with food if desired.
  • Instruct patient using orally disintegrating tablets to place tablet in mouth, wait until it dissolves, and then swallow. Do not cut, crush, or chew.
  • Encourage patient to continue use for 4–6 wk, as directed, to ensure adequate levels to affect depression.
  • Limit amount of drug given in prescription to potentially suicidal patients.
  • Establish appropriate safety precautions if patient experiences adverse CNS effects.
  • Institute appropriate therapy for patient suffering from depression.

Teaching points

  • Take this drug exactly as directed, and as long as directed; it may take a few weeks to realize the benefits of the drug. The drug may be taken with food if desired. Place orally disintegrating tablet in mouth and allow to disintegrate; then swallow. Do not cut, crush, or chew tablets.
  • This drug should not be taken during pregnancy or when nursing a baby; use of barrier contraceptives is suggested.
  • You may experience these side effects: Drowsiness, dizziness, tremor (use caution and avoid driving a car or performing other tasks that require alertness if you experience daytime drowsiness); GI upset (eat frequent small meals, frequent mouth care); alterations in sexual function (it may help to know that this is a drug effect, and will pass when drug therapy is ended).
  • Report severe nausea, vomiting; palpitations; blurred vision; excessive sweating

Tags:

Leave a Reply


*